Back to Results
First PageMeta Content
Piperazines / PDE5 inhibitors / Non-sexuality / Lactams / Sexual arousal / Flibanserin / Hypoactive sexual desire disorder / Erectile dysfunction / Food and Drug Administration / Human sexuality / Chemistry / Organic chemistry


April 2, 2014 Janet Woodcock, MD Director Center for Drug Evaluation and Research Food and Drug Administration[removed]New Hampshire Avenue
Add to Reading List

Document Date: 2014-07-08 10:25:10


Open Document

File Size: 99,15 KB

Share Result on Facebook

City

Ingelheim / /

Company

Sprout Pharmaceuticals / /

Event

FDA Phase / /

Facility

Patient Safety The Jacobs Institute / /

IndustryTerm

healthcare providers / flibanserin applications / /

MedicalCondition

arousal disorders / inflammatory claim / female sexual interest/arousal disorder / erectile dysfunction / Hypoactive sexual desire disorder / male sexual dysfunction / sexual dysfunction / /

Organization

American Psychiatric Association / American Medical Women’s Association Breast Cancer Action Connecticut Center / Food and Drug Administration / Jacobs Institute for Women / office of Women / Center for Drug Evaluation / /

Person

Janet Woodcock / Marsha Henderson / /

Position

Assistant Commissioner / Director / /

Product

DSM-5 / /

ProvinceOrState

Maryland / /

Technology

http / pdf / /

URL

http /

SocialTag